In this application-based continuing pharmacy education activity Dr Erin Emonds, PharmD and Dr. Anuja Rizal, PharmD, R.Ph., CACP discuss the reversal of oral anticoagulation medications.
Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy
This activity is not accredited for technicians
At the conclusion of the activity, pharmacists will be able to:
- Describe the pharmacological agents and therapeutic strategies available for use in patients who experience major bleeding
- Discuss the risks and limitations of current agents available for reversal
- Construct treatment plans to manage severe bleeding in a patient on anticoagulation therapy
Erin Emonds, PharmD
PGY-1 Pharmacy Practice Resident
UConn John Dempsey Hospital
Anuja Rizal, Pharm.D., R.Ph., CACP
Anticoagulation Clinic Coordinator
The University of Connecticut Health Center
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Drs. Emonds and Rizal have no actual or potential conflicts of interest associated with this presentation.
Click on the registration link to register for this activity. The cost is $15.00, if purchased individually. If bundled pricing is used it will be 13 activities (12 hours CE) for $120.00. See registration site for details.
This activity has no grant support
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-19-027-H01-P) Credits will be electronically submitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: June 1, 2019
Planned expiration date: May 31, 2022
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.